Analysis of characteristics of traditional Chinese medicine and western medicine clinical use in patients with viral hepatitis based on real world hospital information system data

Viral hepatitis is clinical multiple strong infectious disease,to know characteristics of traditional Chinese medicine and western medicine clinical use in patients with viral hepatitis,the research object of this study is 41 180 cases of hospitalized patients with viral hepatitis in hospital information system from 17 grade A hospitals,using frequency statistics and association rules method to analyze the traditional Chinese medicine and western medicine clinical useinformation,the drug kinds analysis results;western medicine of reduced glutathione tabletsuse frequency is highest,14 079 cases(34.61%),traditional Chinese medicine of diammonium glycyrrhizinateuse frequency is highest,14 058 cases(34.56%);traditional Chinese medicine and western medicine drug combination in diammonium glycyrrhizinate combined with reduced glutathione tabletsuse frequency is highest,8 607 cases(25.09%).The mechanism of drug classification results:both traditional Chinese medicine and western medicine are the sort of educed enzyme medicine that has the highest percentage of drug use,traditional Chinese medicine 10 983 cases(27.01%),western medicine,9 595 cases(23.59%);traditional Chinese medicine and western medicine combination in a kind of medicine to clear heat and promote diuresis combined with educed enzyme drug use frequency is highest,5 621 cases(13.82%).Through the analysis above.combine traditional Chinese and western medicine therapy for the treatment of viral hepatitis should be given priority.Traditional Chinese medicine to clear heat and promote diuresis combined with western medicine of educed enzyme drug is the most commonly appear in clinical two drug combination scheme,traditional Chinese medicine to clear heat and promote diuresis combined with western medicine of educed enzyme drug and nucleustide analogsis the most commonly appear in clinical three drug combination scheme.